Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte quantity,,RS:0000817,SS/Jr,male,63 days,10,,CMO:0000037,hematocrit,,,,47,%,2.2,6.957,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 35 days) then anesthetic/analgesic,103269,controlled sodium content diet (8 %) (for 35 days),anesthetic/analgesic, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte quantity,,RS:0000817,SS/Jr,male,63 days,15,,CMO:0000037,hematocrit,,,,48.8,%,0.5,1.9365,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 35 days) then anesthetic/analgesic,103268,controlled sodium content diet (0.3 %) (for 35 days),anesthetic/analgesic, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte quantity,,RS:0000786,SR/Jr,male,63 days,13,,CMO:0000037,hematocrit,,,,43.5,%,0.5,1.8028,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 35 days) then anesthetic/analgesic,103267,controlled sodium content diet (8 %) (for 35 days),anesthetic/analgesic, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte quantity,,RS:0000786,SR/Jr,male,63 days,16,,CMO:0000037,hematocrit,,,,45.8,%,0.4,1.6,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 35 days) then anesthetic/analgesic,103266,controlled sodium content diet (0.3 %) (for 35 days),anesthetic/analgesic, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",erythrocyte quantity,,RS:0000811,SS/JrHsdMcwi,female,92 days to 89 days,15,,CMO:0000037,hematocrit,,,,38.8,%,1.4,5.4222,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69482,controlled sodium content diet (0.4 %) (for 35 days),controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days) 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",erythrocyte quantity,,RS:0000145,BN/NHsdMcwi,female,92 days to 89 days,15,,CMO:0000037,hematocrit,,,,41.6,%,0.4,1.5492,MMO:0000214,hematocrit analysis,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69481,controlled sodium content diet (0.4 %) (for 35 days),controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days)